De-escalating elective nodal irradiation for nasopharyngeal carcinoma

Affiliations

¹ Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA 94305, USA.
² Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA 94305, USA. Electronic address: qle@stanford.edu.

Comment

Jacob A Miller et al. Lancet Oncol. 2022 Apr.

. 2022 Apr;23(4):441-443.

doi: 10.1016/S1470-2045(22)00096-1. Epub 2022 Feb 28.

¹ Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA 94305, USA.
² Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA 94305, USA. Electronic address: qle@stanford.edu.

No abstract available

Conflict of interest statement

We declare no competing interests.

Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.
Tang LL, Huang CL, Zhang N, Jiang W, Wu YS, Huang SH, Mao YP, Liu Q, Li JB, Liang SQ, Qin GJ, Hu WH, Sun Y, Xie FY, Chen L, Zhou GQ, Ma J. Tang LL, et al. Lancet Oncol. 2022 Apr;23(4):479-490. doi: 10.1016/S1470-2045(22)00058-4. Epub 2022 Feb 28. Lancet Oncol. 2022. PMID: 35240053 Clinical Trial.